Diabetic Foot Ulcer Treatment Market
PUBLISHED: 2024 ID: SMRC27524
SHARE
SHARE

Diabetic Foot Ulcer Treatment Market

Diabetic Foot Ulcer Treatment Market Forecasts to 2030 - Global Analysis by Treatment Type (Wound Care Dressings, Wound Care Devices, Biologics, Antibiotics and Surgical Procedures), Ulcer Type, End User and By Geography

4.2 (47 reviews)
4.2 (47 reviews)
Published: 2024 ID: SMRC27524

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2022-2030

Estimated Year Value (2024)

US $9.02 BN

Projected Year Value (2030)

US $14.55 BN

CAGR (2024 - 2030)

8.3%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Diabetic Foot Ulcer Treatment Market is accounted for $9.02 billion in 2024 and is expected to reach $14.55 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Diabetic foot ulcer treatment encompasses a range of medical and therapeutic interventions aimed at healing ulcers resulting from diabetes-related complications. These treatments include wound care management, such as debridement and the application of advanced dressings, as well as the use of antimicrobial agents to prevent infection. In severe cases, surgical interventions may be necessary. Additionally, patient education on proper foot care and diabetes management plays a vital role in preventing ulcer recurrence. The ultimate goal is to promote healing, reduce complications, and enhance the quality of life for affected individuals.


 
Market Dynamics: 

Driver: 

Rising Diabetes Prevalence 

Rising diabetes prevalence significantly impacts the market by increasing the number of patients at risk for foot complications. As diabetes cases grow, more individuals experience neuropathy and poor circulation, leading to a higher incidence of foot ulcers. This trend drives demand for advanced treatment options, including specialized wound care products and therapies. Additionally, healthcare systems are compelled to implement comprehensive management strategies to address these challenges, further fueling market growth.

Restraint:

High Treatment Costs

High treatment costs significantly impact the market by limiting access to advanced therapies for many patients. The expense associated with specialized wound care products and technologies can discourage timely intervention, leading to increased complications and worsening conditions. This financial barrier may result in delayed treatment, ultimately affecting patient outcomes. Thus, it hinders the growth opf the market.

Opportunity:

Advancements in Technology

Advancements in technology are transforming the market by introducing innovative wound care solutions, such as smart dressings, bioactive materials, and telehealth services. These technologies enhance the effectiveness of treatment, promote faster healing, and allow for better patient monitoring. The integration of data analytics and mobile health applications facilitates personalized care, improving outcomes and patient engagement. As healthcare providers increasingly adopt these technologies, the demand for advanced diabetic foot ulcer treatments grows, thus it drives the growth of the market.

Threat:

Limited Healthcare Access

Limited healthcare access impacts the market by hindering timely diagnosis and intervention for patients. In underserved regions, a lack of medical facilities and specialized care can result in delayed treatments, increasing the risk of complications like infections and amputations. This scenario leads to poorer patient outcomes and higher long-term healthcare costs, emphasizing the need for improved healthcare infrastructure and accessibility to ensure effective management of diabetic foot ulcers, thus it hampers the growth of the market.
 
Covid-19 Impact: 

The COVID-19 pandemic adversely affected the diabetic foot ulcer treatment market by causing delays in elective procedures and reducing patient visits to healthcare facilities due to lockdowns. This leads to increased complications and worsening conditions among diabetic patients. However, the crisis also spurred innovation in telehealth and remote monitoring, improving access to care.

The neuropathic ulcers segment is expected to be the largest during the forecast period

The neuropathic ulcers segment is expected to be the largest during the forecast period as these ulcers often result from nerve damage, leading to reduced sensation and unrecognized injuries. The growing prevalence of neuropathic ulcers drives demand for specialized treatments and advanced care solutions. As healthcare providers focus on comprehensive management strategies, including regular screening and tailored therapies, the market for diabetic foot ulcer treatments continues to expand, emphasizing the importance of addressing neuropathic conditions in patient care.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is expected to have the highest CAGR during the forecast period because Increased focus on multidisciplinary approaches, including podiatry, wound care, and diabetes management, enhances patient outcomes. Hospitals are also instrumental in raising awareness about the importance of early intervention and preventative care. Moreover, their investment in advanced technologies and wound care products drives innovation in the market, improving accessibility and efficiency in treating diabetic foot ulcers across the healthcare system.

Region with largest share:

North America is projected to hold the largest market share during the forecast period as it addresses the rising incidence of diabetes and its complications. Innovative therapies and advanced wound care technologies improve patient management, reducing the risk of infections and amputations. This market's growth enhances access to effective treatments, ultimately leading to better patient quality of life. Increased awareness among healthcare providers further emphasizes the importance of preventative care and timely intervention, fostering a comprehensive approach to managing diabetic foot ulcers in the region.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period owing to rising prevalence of diabetes and related complications. Increasing awareness of proper foot care and advancements in treatment technologies are driving demand for effective therapies. Additionally, government initiatives aimed at improving diabetes management and healthcare infrastructure are enhancing access to treatments. This growth is further supported by the expanding aging population and the increasing incidence of obesity.

Key players in the market

Some of the key players in Diabetic Foot Ulcer Treatment Market include 3M Healthcare, Acelity L.P. Inc. (KCI), Advanced Tissue, Alliqua Biomedical, Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Derma Sciences Inc., Hollister Incorporated, Integra LifeSciences Corporation, Medline Industries, Inc., Medtronic Plc, Molnlycke Health Care AB, Organogenesis Inc., Osiris Therapeutics, Inc., Paul Hartmann AG, Smith & Nephew Plc and Wound Care Innovations, LLC.

Key Developments:

In August 2024, Cardinal Health expanded medical product distribution footprint in Northeast Ohio, to support its U.S. Medical Products and Distribution business.

In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

In September 2023, Cardinal Health announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to help provide enteral feeding patients with more options to meet their personalized needs throughout their enteral feeding journey.

Treatment Types Covered:
• Wound Care Dressings 
• Wound Care Devices
• Biologics
• Antibiotics
• Surgical Procedures

Ulcer Types Covered:
• Neuropathic Ulcers
• Ischemic Ulcers
• Neuroischemic Ulcers 

End Users Covered:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary     
       
2 Preface    
 
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 End User Analysis    
 3.7 Emerging Markets    
 3.8 Impact of Covid-19    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Diabetic Foot Ulcer Treatment Market, By Treatment Type
 5.1 Introduction    
 5.2 Wound Care Dressings   
  5.2.1 Foam Dressings   
  5.2.2 Hydrocolloid Dressings  
  5.2.3 Alginate Dressings   
  5.2.4 Hydrogel Dressings   
  5.2.5 Other Advanced Dressings  
 5.3 Wound Care Devices   
  5.3.1 Negative Pressure Wound Therapy (NPWT)
  5.3.2 Ultrasound Therapy Devices  
  5.3.3 Hyperbaric Oxygen Therapy (HBOT) 
  5.3.4 Electrical Stimulation Devices  
 5.4 Biologics     
  5.4.1 Skin Substitutes   
  5.4.2 Tissue-Engineered Products 
 5.5 Antibiotics    
  5.5.1 Topical Antibiotics   
  5.5.2 Oral Antibiotics   
 5.6 Surgical Procedures    
  5.6.1 Debridement   
  5.6.2 Revascularization   
  5.6.3 Skin Grafting   
       
6 Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type 
 6.1 Introduction    
 6.2 Neuropathic Ulcers    
 6.3 Ischemic Ulcers    
 6.4 Neuroischemic Ulcers   
       
7 Global Diabetic Foot Ulcer Treatment Market, By End User 
 7.1 Introduction    
 7.2 Hospitals     
 7.3 Specialty Clinics    
 7.4 Ambulatory Surgical Centers   
 7.5 Home Care Settings    
 7.6 Other End Users    
       
8 Global Diabetic Foot Ulcer Treatment Market, By Geography 
 8.1 Introduction    
 8.2 North America    
  8.2.1 US    
  8.2.2 Canada    
  8.2.3 Mexico    
 8.3 Europe     
  8.3.1 Germany    
  8.3.2 UK    
  8.3.3 Italy    
  8.3.4 France    
  8.3.5 Spain    
  8.3.6 Rest of Europe   
 8.4 Asia Pacific    
  8.4.1 Japan    
  8.4.2 China    
  8.4.3 India    
  8.4.4 Australia    
  8.4.5 New Zealand   
  8.4.6 South Korea   
  8.4.7 Rest of Asia Pacific   
 8.5 South America    
  8.5.1 Argentina   
  8.5.2 Brazil    
  8.5.3 Chile    
  8.5.4 Rest of South America  
 8.6 Middle East & Africa   
  8.6.1 Saudi Arabia   
  8.6.2 UAE    
  8.6.3 Qatar    
  8.6.4 South Africa   
  8.6.5 Rest of Middle East & Africa  
       
9 Key Developments     
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers   
 9.3 New Product Launch   
 9.4 Expansions    
 9.5 Other Key Strategies   
       
10 Company Profiling     
 10.1 3M Healthcare    
 10.2 Acelity L.P. Inc. (KCI)   
 10.3 Advanced Tissue    
 10.4 Alliqua Biomedical, Inc.   
 10.5 B. Braun Melsungen AG   
 10.6 BSN Medical GmbH    
 10.7 Cardinal Health, Inc.   
 10.8 Coloplast A/S    
 10.9 ConvaTec Group Plc    
 10.10 Derma Sciences Inc.    
 10.11 Hollister Incorporated   
 10.12 Integra LifeSciences Corporation  
 10.13 Medline Industries, Inc.   
 10.14 Medtronic Plc    
 10.15 Molnlycke Health Care AB   
 10.16 Organogenesis Inc.    
 10.17 Osiris Therapeutics, Inc.   
 10.18 Paul Hartmann AG    
 10.19 Smith & Nephew Plc   
 10.20 Wound Care Innovations, LLC   
       
List of Tables      
1 Global Diabetic Foot Ulcer Treatment Market Outlook, By Region (2022-2030) ($MN)
2 Global Diabetic Foot Ulcer Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
3 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Dressings (2022-2030) ($MN)
4 Global Diabetic Foot Ulcer Treatment Market Outlook, By Foam Dressings (2022-2030) ($MN)
5 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
6 Global Diabetic Foot Ulcer Treatment Market Outlook, By Alginate Dressings (2022-2030) ($MN)
7 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hydrogel Dressings (2022-2030) ($MN)
8 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other Advanced Dressings (2022-2030) ($MN)
9 Global Diabetic Foot Ulcer Treatment Market Outlook, By Wound Care Devices (2022-2030) ($MN)
10 Global Diabetic Foot Ulcer Treatment Market Outlook, By Negative Pressure Wound Therapy (NPWT) (2022-2030) ($MN)
11 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ultrasound Therapy Devices (2022-2030) ($MN)
12 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hyperbaric Oxygen Therapy (HBOT) (2022-2030) ($MN)
13 Global Diabetic Foot Ulcer Treatment Market Outlook, By Electrical Stimulation Devices (2022-2030) ($MN)
14 Global Diabetic Foot Ulcer Treatment Market Outlook, By Biologics (2022-2030) ($MN)
15 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Substitutes (2022-2030) ($MN)
16 Global Diabetic Foot Ulcer Treatment Market Outlook, By Tissue-Engineered Products (2022-2030) ($MN)
17 Global Diabetic Foot Ulcer Treatment Market Outlook, By Antibiotics (2022-2030) ($MN)
18 Global Diabetic Foot Ulcer Treatment Market Outlook, By Topical Antibiotics (2022-2030) ($MN)
19 Global Diabetic Foot Ulcer Treatment Market Outlook, By Oral Antibiotics (2022-2030) ($MN)
20 Global Diabetic Foot Ulcer Treatment Market Outlook, By Surgical Procedures (2022-2030) ($MN)
21 Global Diabetic Foot Ulcer Treatment Market Outlook, By Debridement (2022-2030) ($MN)
22 Global Diabetic Foot Ulcer Treatment Market Outlook, By Revascularization (2022-2030) ($MN)
23 Global Diabetic Foot Ulcer Treatment Market Outlook, By Skin Grafting (2022-2030) ($MN)
24 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ulcer Type (2022-2030) ($MN)
25 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuropathic Ulcers (2022-2030) ($MN)
26 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ischemic Ulcers (2022-2030) ($MN)
27 Global Diabetic Foot Ulcer Treatment Market Outlook, By Neuroischemic Ulcers (2022-2030) ($MN)
28 Global Diabetic Foot Ulcer Treatment Market Outlook, By End User (2022-2030) ($MN)
29 Global Diabetic Foot Ulcer Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
30 Global Diabetic Foot Ulcer Treatment Market Outlook, By Specialty Clinics (2022-2030) ($MN)
31 Global Diabetic Foot Ulcer Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
32 Global Diabetic Foot Ulcer Treatment Market Outlook, By Home Care Settings (2022-2030) ($MN)
33 Global Diabetic Foot Ulcer Treatment Market Outlook, By Other End Users (2022-2030) ($MN)
       
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials